Deciphera Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Deciphera Pharmaceuticals Inc Stock! Deciphera Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Deciphera Pharmaceuticals Inc Stock!


Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The company is headquartered in Waltham, Massachusetts and currently employs 300 full-time employees. The company went IPO on 2017-09-28. The firm has developed a switch-control kinase inhibitor platform in kinase biology to execute its strategy to develop a portfolio of medicines. The firm’s QINLOCK, is a switch-control kinase inhibitor, engineered using its drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor (GIST). The firm has two additional clinical-stage assets, vimseltinib and DCC-3116. Vimseltinib is an investigational, orally administered, potent, and highly selective switch-control kinase inhibitor of the colony stimulating factor 1 receptor (CSF1R). Vimseltinib is in a pivotal phase III study in patients with tenosynovial giant cell tumor (TGCT). DCC-3116 is an investigational, orally administered, potent, and highly selective switch-control inhibitor of the ULK kinase.



Deciphera Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Deciphera Pharmaceuticals Inc Stock! performance

  • Employees 300
  • Company HQ Waltham
  • Website https://www.deciphera.com/
  • DCPH Asset Type Common Stock
  • DCPH Market Capitalization 2.2B
  • Earnings Per Share -2.21
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth 0

If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam with an interest in the healthcare sector, Deciphera Pharmaceuticals might be a stock worth considering. Deciphera Pharmaceuticals is an innovative biotechnology company focused on developing precision medicines for cancer treatment. With its cutting-edge platform, this US-based company has delivered promising results in the oncology field. To invest in Deciphera Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam, follow these steps: 1. Find a reliable online investment platform like Zorion that offers access to real US stocks. 2. Open an account and complete the necessary verification process. 3. Deposit funds into your account using the available payment methods. 4. Search for Deciphera Pharmaceuticals using the stock ticker symbol (DCPH) on the platform. 5. Review the company’s financials, analysis, and any available investment insights on the platform. 6. After conducting your research, make an informed decision and choose the amount you want to invest. 7. Place your order, specifying the number of shares you wish to purchase and the order type (e.g., market or limit). 8. Monitor your investment periodically and stay updated with any news or updates regarding Deciphera Pharmaceuticals. By investing in Deciphera Pharmaceuticals, you have the opportunity to support the development of groundbreaking cancer treatments while potentially earning a return on your investment. Remember to consult with a financial advisor or do thorough research before making any investment decisions.


Want To Buy Deciphera Pharmaceuticals Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: